Adjusting IV Iron and EPO Doses in Patients on Hemodialysis Prior to Surgery: Can We Protect Our Patients From Iron-Deficiency Anemian

Adjusting IV Iron and EPO Doses in Patients on Hemodialysis Prior to Surgery: Can We Protect Our Patients From Iron-Deficiency Anemian

Identification: nnj_ja06A7
Issue: July-August 2006
Volume: Vol. 33, No. 4

Standard: $30.00

Description

This article is available to members for free.

Goal: To increase the knowledge of those caring for patients on hemodialysis about adequate dosing of Iron and EPO prior to surgery.

Objectives:

  1. Examine the implications of anemia in patients on hemodialysis who are scheduled for surgery.
  2. Describe key strategies to improve anemmia management in presurgical patients on hemodialysis.
  3. Summarize patient case studies in which IV Iron and EPO doses were adjusted prior to surgery in order to improve anemia outcomes.


Note: This article is supported by an unrestricted educational grant from Watson, Pharma Inc. The manuscript has underhone peer review. The information does not necessarily reflect the opinions of ANNA or the sponsor.

Author(s)

Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content